Self-monitoring Blood Glucose Devices Market Size, Share and Growth Outlook 2026: By Product Type, By Connectivity Type, By Application, By Distribution Channel, By End-User, Companies to 2034
The global Self-monitoring Blood Glucose Devices Market size is forecast to increase from $10.69 Billion in 2026 to $20.38 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.
The Self-monitoring Blood Glucose Devices market report provides detailed analysis and outlook of Self-monitoring Blood Glucose Devices segments including By Product Type (Blood Glucose Meters, Testing Strips, Lancets and Lancing Devices), By Connectivity Type (Bluetooth-Enabled Devices, Cellular/Wi-Fi Connected Devices, Non-Connected Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (Retail Pharmacies and Drugstores, Online Pharmacies / E-commerce Channels, Hospital Pharmacies, Institutional Sales/Direct Tenders), By End-User (Home Care / Self-Testing, Hospitals and Diagnostic Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Self-Monitoring Blood Glucose (SMBG) Devices Industry Overview
Device Safety, Integrated Diabetes Management, and Continuous Monitoring Technologies Are Reshaping the SMBG Market
The Self-Monitoring Blood Glucose (SMBG) Devices industry continues to evolve as diabetes management increasingly shifts toward integrated, connected, and patient-centric monitoring ecosystems. While traditional blood glucose meters remain essential for millions of patients worldwide, the market is experiencing substantial transformation driven by continuous glucose monitoring technologies, automated insulin delivery systems, digital health integration, and enhanced regulatory oversight. Manufacturers are increasingly focused on improving measurement accuracy, device interoperability, patient safety, and seamless integration with broader diabetes management platforms to support individualized treatment strategies and improve clinical outcomes.
Regulatory Oversight and Device Safety Are Driving Product Quality Improvements
One of the most significant trends shaping the SMBG devices market is the growing emphasis on device reliability, software validation, and patient safety. Regulatory agencies continue to strengthen oversight of glucose monitoring technologies to minimize risks associated with inaccurate readings or delayed treatment decisions. Reflecting this trend, the U.S. Food and Drug Administration issued a Class I recall for TRUE METRIX, TRUE METRIX AIR, and TRUE METRIX GO blood glucose monitoring systems following identification of a software-related issue affecting interpretation of critical hyperglycemic events. The subsequent corrective actions underscore the increasing importance of robust software design, post-market surveillance, and rapid corrective response mechanisms within the diabetes monitoring industry. Similarly, Abbott continued implementation of corrective actions for selected FreeStyle Libre 3 and Libre 3 Plus sensors through dedicated replacement programs, highlighting the industry's commitment to maintaining device reliability and patient confidence.
Connected Monitoring and Automated Diabetes Management Are Accelerating Market Transformation
The SMBG market is also experiencing continued convergence with continuous glucose monitoring and automated insulin delivery technologies. Patients and healthcare providers increasingly seek integrated diabetes management solutions capable of providing continuous data streams and automated therapeutic adjustments. Dexcom's continued expansion of the G7 continuous glucose monitoring ecosystem, including interoperability with insulin delivery systems such as Tandem t:slim X2 and Omnipod 5, reflects the growing adoption of closed-loop and hybrid diabetes management platforms. These developments demonstrate the broader transition from episodic blood glucose measurement toward comprehensive, connected diabetes management ecosystems that combine continuous monitoring, automated insulin delivery, and digital health technologies to improve glycemic control and patient quality of life.
Self-monitoring Blood Glucose Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Self-monitoring Blood Glucose Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, LifeScan Inc., Ascensia Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ARKRAY Inc., Becton, Dickinson and Company. The Self-monitoring Blood Glucose Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Self-monitoring Blood Glucose Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Self-monitoring Blood Glucose Devices industry include- Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, LifeScan Inc., Ascensia Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ARKRAY Inc., Becton, Dickinson and Company. The Self-monitoring Blood Glucose Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Self-monitoring Blood Glucose Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Self-monitoring Blood Glucose Devices market remains one of the strongest-performing segments in the country.
The US Self-monitoring Blood Glucose Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Self-monitoring Blood Glucose Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Self-monitoring Blood Glucose Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Self-monitoring Blood Glucose Devices markets
Canada's strong Self-monitoring Blood Glucose Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Self-monitoring Blood Glucose Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Self-monitoring Blood Glucose Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Self-monitoring Blood Glucose Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Self-monitoring Blood Glucose Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Self-monitoring Blood Glucose Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Self-monitoring Blood Glucose Devices market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Self-monitoring Blood Glucose Devices sales through 2034
France Self-monitoring Blood Glucose Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Self-monitoring Blood Glucose Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Self-monitoring Blood Glucose Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Self-monitoring Blood Glucose Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Self-monitoring Blood Glucose Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Self-monitoring Blood Glucose Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Self-monitoring Blood Glucose Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Self-monitoring Blood Glucose Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Self-monitoring Blood Glucose Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Self-monitoring Blood Glucose Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Self-monitoring Blood Glucose Devices Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Self-monitoring Blood Glucose Devices Market Segmentation
By Product Type
Blood Glucose Meters
Testing Strips
Lancets and Lancing Devices
By Connectivity Type
Bluetooth-Enabled Devices
Cellular/Wi-Fi Connected Devices
Non-Connected Devices
By Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
By Distribution Channel
Retail Pharmacies and Drugstores
Online Pharmacies / E-commerce Channels
Hospital Pharmacies
Institutional Sales/Direct Tenders
By End-User
Home Care / Self-Testing
Hospitals and Diagnostic Clinics
Leading Companies in Self-monitoring Blood Glucose Devices Industry (2026)
Abbott Laboratories
Roche Diagnostics
Dexcom, Inc.
Medtronic plc
LifeScan Inc.
Ascensia Diabetes Care
B. Braun Melsungen AG
Terumo Corporation
ARKRAY Inc.
Becton, Dickinson and Company
Countries Included
The Self-monitoring Blood Glucose Devices market report provides detailed analysis and outlook of Self-monitoring Blood Glucose Devices segments including By Product Type (Blood Glucose Meters, Testing Strips, Lancets and Lancing Devices), By Connectivity Type (Bluetooth-Enabled Devices, Cellular/Wi-Fi Connected Devices, Non-Connected Devices), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (Retail Pharmacies and Drugstores, Online Pharmacies / E-commerce Channels, Hospital Pharmacies, Institutional Sales/Direct Tenders), By End-User (Home Care / Self-Testing, Hospitals and Diagnostic Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Self-Monitoring Blood Glucose (SMBG) Devices Industry Overview
Device Safety, Integrated Diabetes Management, and Continuous Monitoring Technologies Are Reshaping the SMBG Market
The Self-Monitoring Blood Glucose (SMBG) Devices industry continues to evolve as diabetes management increasingly shifts toward integrated, connected, and patient-centric monitoring ecosystems. While traditional blood glucose meters remain essential for millions of patients worldwide, the market is experiencing substantial transformation driven by continuous glucose monitoring technologies, automated insulin delivery systems, digital health integration, and enhanced regulatory oversight. Manufacturers are increasingly focused on improving measurement accuracy, device interoperability, patient safety, and seamless integration with broader diabetes management platforms to support individualized treatment strategies and improve clinical outcomes.
Regulatory Oversight and Device Safety Are Driving Product Quality Improvements
One of the most significant trends shaping the SMBG devices market is the growing emphasis on device reliability, software validation, and patient safety. Regulatory agencies continue to strengthen oversight of glucose monitoring technologies to minimize risks associated with inaccurate readings or delayed treatment decisions. Reflecting this trend, the U.S. Food and Drug Administration issued a Class I recall for TRUE METRIX, TRUE METRIX AIR, and TRUE METRIX GO blood glucose monitoring systems following identification of a software-related issue affecting interpretation of critical hyperglycemic events. The subsequent corrective actions underscore the increasing importance of robust software design, post-market surveillance, and rapid corrective response mechanisms within the diabetes monitoring industry. Similarly, Abbott continued implementation of corrective actions for selected FreeStyle Libre 3 and Libre 3 Plus sensors through dedicated replacement programs, highlighting the industry's commitment to maintaining device reliability and patient confidence.
Connected Monitoring and Automated Diabetes Management Are Accelerating Market Transformation
The SMBG market is also experiencing continued convergence with continuous glucose monitoring and automated insulin delivery technologies. Patients and healthcare providers increasingly seek integrated diabetes management solutions capable of providing continuous data streams and automated therapeutic adjustments. Dexcom's continued expansion of the G7 continuous glucose monitoring ecosystem, including interoperability with insulin delivery systems such as Tandem t:slim X2 and Omnipod 5, reflects the growing adoption of closed-loop and hybrid diabetes management platforms. These developments demonstrate the broader transition from episodic blood glucose measurement toward comprehensive, connected diabetes management ecosystems that combine continuous monitoring, automated insulin delivery, and digital health technologies to improve glycemic control and patient quality of life.
Self-monitoring Blood Glucose Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Self-monitoring Blood Glucose Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, LifeScan Inc., Ascensia Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ARKRAY Inc., Becton, Dickinson and Company. The Self-monitoring Blood Glucose Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Self-monitoring Blood Glucose Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Self-monitoring Blood Glucose Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Self-monitoring Blood Glucose Devices companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Self-monitoring Blood Glucose Devices markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Self-monitoring Blood Glucose Devices industry include- Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, LifeScan Inc., Ascensia Diabetes Care, B. Braun Melsungen AG, Terumo Corporation, ARKRAY Inc., Becton, Dickinson and Company. The Self-monitoring Blood Glucose Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Self-monitoring Blood Glucose Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Self-monitoring Blood Glucose Devices market remains one of the strongest-performing segments in the country.
The US Self-monitoring Blood Glucose Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Self-monitoring Blood Glucose Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Self-monitoring Blood Glucose Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Self-monitoring Blood Glucose Devices markets
Canada's strong Self-monitoring Blood Glucose Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Self-monitoring Blood Glucose Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Self-monitoring Blood Glucose Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Self-monitoring Blood Glucose Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Self-monitoring Blood Glucose Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Self-monitoring Blood Glucose Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Self-monitoring Blood Glucose Devices market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Self-monitoring Blood Glucose Devices sales through 2034
France Self-monitoring Blood Glucose Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Self-monitoring Blood Glucose Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Self-monitoring Blood Glucose Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Self-monitoring Blood Glucose Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Self-monitoring Blood Glucose Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Self-monitoring Blood Glucose Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Self-monitoring Blood Glucose Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Self-monitoring Blood Glucose Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Self-monitoring Blood Glucose Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Self-monitoring Blood Glucose Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Self-monitoring Blood Glucose Devices Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Self-monitoring Blood Glucose Devices Market Segmentation
By Product Type
Blood Glucose Meters
Testing Strips
Lancets and Lancing Devices
By Connectivity Type
Bluetooth-Enabled Devices
Cellular/Wi-Fi Connected Devices
Non-Connected Devices
By Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
By Distribution Channel
Retail Pharmacies and Drugstores
Online Pharmacies / E-commerce Channels
Hospital Pharmacies
Institutional Sales/Direct Tenders
By End-User
Home Care / Self-Testing
Hospitals and Diagnostic Clinics
Leading Companies in Self-monitoring Blood Glucose Devices Industry (2026)
Abbott Laboratories
Roche Diagnostics
Dexcom, Inc.
Medtronic plc
LifeScan Inc.
Ascensia Diabetes Care
B. Braun Melsungen AG
Terumo Corporation
ARKRAY Inc.
Becton, Dickinson and Company
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Self-monitoring Blood Glucose Devices Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Self-monitoring Blood Glucose Devices Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Self-monitoring Blood Glucose Devices Markets in 2026
3.2. Global Historic and Forecast Self-monitoring Blood Glucose Devices Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Self-monitoring Blood Glucose Devices Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Self-monitoring Blood Glucose Devices Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Self-monitoring Blood Glucose Devices Value Chain
CHAPTER 4- SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Self-monitoring Blood Glucose Devices Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Blood Glucose Meters
Testing Strips
Lancets and Lancing Devices
By Connectivity Type
Bluetooth-Enabled Devices
Cellular/Wi-Fi Connected Devices
Non-Connected Devices
By Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
By Distribution Channel
Retail Pharmacies and Drugstores
Online Pharmacies / E-commerce Channels
Hospital Pharmacies
Institutional Sales/Direct Tenders
By End-User
Home Care / Self-Testing
Hospitals and Diagnostic Clinics
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Self-monitoring Blood Glucose Devices Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
7.5. North America Self-monitoring Blood Glucose Devices Market Size Outlook by Type
7.6. North America Self-monitoring Blood Glucose Devices Market Size Outlook by Application
7.7. North America Self-monitoring Blood Glucose Devices Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Self-monitoring Blood Glucose Devices Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Self-monitoring Blood Glucose Devices Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Self-monitoring Blood Glucose Devices Companies
CHAPTER 8- EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Self-monitoring Blood Glucose Devices Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
8.5. Europe Self-monitoring Blood Glucose Devices Market Size Outlook by Type
8.6. Europe Self-monitoring Blood Glucose Devices Market Size Outlook by Application
8.7. Europe Self-monitoring Blood Glucose Devices Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Self-monitoring Blood Glucose Devices Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Self-monitoring Blood Glucose Devices Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Self-monitoring Blood Glucose Devices Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Self-monitoring Blood Glucose Devices Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Self-monitoring Blood Glucose Devices Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Self-monitoring Blood Glucose Devices Companies
CHAPTER 9- ASIA PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Self-monitoring Blood Glucose Devices Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Self-monitoring Blood Glucose Devices Market Size Outlook by Type
9.6. Asia Pacific Self-monitoring Blood Glucose Devices Market Size Outlook by Application
9.7. Asia Pacific Self-monitoring Blood Glucose Devices Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Self-monitoring Blood Glucose Devices Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Self-monitoring Blood Glucose Devices Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Self-monitoring Blood Glucose Devices Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Self-monitoring Blood Glucose Devices Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Self-monitoring Blood Glucose Devices Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Self-monitoring Blood Glucose Devices Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Self-monitoring Blood Glucose Devices Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
10.5. South and Central America Self-monitoring Blood Glucose Devices Market Size Outlook by Type
10.6. South and Central America Self-monitoring Blood Glucose Devices Market Size Outlook by Application
10.7. South and Central America Self-monitoring Blood Glucose Devices Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Self-monitoring Blood Glucose Devices Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Self-monitoring Blood Glucose Devices Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Self-monitoring Blood Glucose Devices Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Self-monitoring Blood Glucose Devices Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Self-monitoring Blood Glucose Devices Market Size Outlook by Type
11.6. Middle East and Africa Self-monitoring Blood Glucose Devices Market Size Outlook by Application
11.7. Middle East and Africa Self-monitoring Blood Glucose Devices Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Self-monitoring Blood Glucose Devices Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Self-monitoring Blood Glucose Devices Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Self-monitoring Blood Glucose Devices Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Self-monitoring Blood Glucose Devices Industry
Abbott Laboratories
Roche Diagnostics
Dexcom, Inc.
Medtronic plc
LifeScan Inc.
Ascensia Diabetes Care
B. Braun Melsungen AG
Terumo Corporation
ARKRAY Inc.
Becton, Dickinson and Company
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Self-monitoring Blood Glucose Devices Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Self-monitoring Blood Glucose Devices Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Self-monitoring Blood Glucose Devices Markets in 2026
3.2. Global Historic and Forecast Self-monitoring Blood Glucose Devices Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Self-monitoring Blood Glucose Devices Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Self-monitoring Blood Glucose Devices Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Self-monitoring Blood Glucose Devices Value Chain
CHAPTER 4- SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Self-monitoring Blood Glucose Devices Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Blood Glucose Meters
Testing Strips
Lancets and Lancing Devices
By Connectivity Type
Bluetooth-Enabled Devices
Cellular/Wi-Fi Connected Devices
Non-Connected Devices
By Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
By Distribution Channel
Retail Pharmacies and Drugstores
Online Pharmacies / E-commerce Channels
Hospital Pharmacies
Institutional Sales/Direct Tenders
By End-User
Home Care / Self-Testing
Hospitals and Diagnostic Clinics
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Self-monitoring Blood Glucose Devices Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
7.5. North America Self-monitoring Blood Glucose Devices Market Size Outlook by Type
7.6. North America Self-monitoring Blood Glucose Devices Market Size Outlook by Application
7.7. North America Self-monitoring Blood Glucose Devices Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Self-monitoring Blood Glucose Devices Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Self-monitoring Blood Glucose Devices Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Self-monitoring Blood Glucose Devices Companies
CHAPTER 8- EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Self-monitoring Blood Glucose Devices Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
8.5. Europe Self-monitoring Blood Glucose Devices Market Size Outlook by Type
8.6. Europe Self-monitoring Blood Glucose Devices Market Size Outlook by Application
8.7. Europe Self-monitoring Blood Glucose Devices Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Self-monitoring Blood Glucose Devices Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Self-monitoring Blood Glucose Devices Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Self-monitoring Blood Glucose Devices Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Self-monitoring Blood Glucose Devices Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Self-monitoring Blood Glucose Devices Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Self-monitoring Blood Glucose Devices Companies
CHAPTER 9- ASIA PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Self-monitoring Blood Glucose Devices Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Self-monitoring Blood Glucose Devices Market Size Outlook by Type
9.6. Asia Pacific Self-monitoring Blood Glucose Devices Market Size Outlook by Application
9.7. Asia Pacific Self-monitoring Blood Glucose Devices Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Self-monitoring Blood Glucose Devices Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Self-monitoring Blood Glucose Devices Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Self-monitoring Blood Glucose Devices Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Self-monitoring Blood Glucose Devices Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Self-monitoring Blood Glucose Devices Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Self-monitoring Blood Glucose Devices Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Self-monitoring Blood Glucose Devices Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
10.5. South and Central America Self-monitoring Blood Glucose Devices Market Size Outlook by Type
10.6. South and Central America Self-monitoring Blood Glucose Devices Market Size Outlook by Application
10.7. South and Central America Self-monitoring Blood Glucose Devices Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Self-monitoring Blood Glucose Devices Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Self-monitoring Blood Glucose Devices Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Self-monitoring Blood Glucose Devices Companies
CHAPTER 11- MIDDLE EAST AND AFRICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Self-monitoring Blood Glucose Devices Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Self-monitoring Blood Glucose Devices Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Self-monitoring Blood Glucose Devices Market Size Outlook by Type
11.6. Middle East and Africa Self-monitoring Blood Glucose Devices Market Size Outlook by Application
11.7. Middle East and Africa Self-monitoring Blood Glucose Devices Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Self-monitoring Blood Glucose Devices Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Self-monitoring Blood Glucose Devices Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Self-monitoring Blood Glucose Devices Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Self-monitoring Blood Glucose Devices Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Self-monitoring Blood Glucose Devices Industry
Abbott Laboratories
Roche Diagnostics
Dexcom, Inc.
Medtronic plc
LifeScan Inc.
Ascensia Diabetes Care
B. Braun Melsungen AG
Terumo Corporation
ARKRAY Inc.
Becton, Dickinson and Company
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
